Skip to main content
PMC home page
Emergency Medicine Journal : EMJ logoLink to Emergency Medicine Journal : EMJ
. 2005 Sep;22(9):612–616. doi: 10.1136/emj.2003.009613

Naloxone in opioid poisoning: walking the tightrope

S Clarke 1, P Dargan 1, A Jones 1
PMCID: PMC1726910  PMID: 16113176

Full Text

The Full Text of this article is available as a PDF (79.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen S. C. Letter: Problems with naloxone. Br Med J. 1975 Aug 16;3(5980):434–434. doi: 10.1136/bmj.3.5980.434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen T. No adverse reaction. Ann Emerg Med. 1989 Jan;18(1):116–116. doi: 10.1016/s0196-0644(89)80351-8. [DOI] [PubMed] [Google Scholar]
  3. Andree R. A. Sudden death following naloxone administration. Anesth Analg. 1980 Oct;59(10):782–784. [PubMed] [Google Scholar]
  4. Azar I., Turndorf H. Severe hypertension and multiple atrial premature contractions following naloxone administration. Anesth Analg. 1979 Nov-Dec;58(6):524–525. doi: 10.1213/00000539-197911000-00019. [DOI] [PubMed] [Google Scholar]
  5. Barton Erik D., Ramos Joseph, Colwell Christopher, Benson Jeff, Baily Jeff, Dunn William. Intranasal administration of naloxone by paramedics. Prehosp Emerg Care. 2002 Jan-Mar;6(1):54–58. doi: 10.1080/10903120290938797. [DOI] [PubMed] [Google Scholar]
  6. Bateman D. N., Bain M., Gorman D., Murphy D. Changes in paracetamol, antidepressants and opioid poisoning in Scotland during the 1990s. QJM. 2003 Feb;96(2):125–132. doi: 10.1093/qjmed/hcg015. [DOI] [PubMed] [Google Scholar]
  7. Berkowitz B. A. The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone. Clin Pharmacokinet. 1976;1(3):219–230. doi: 10.2165/00003088-197601030-00004. [DOI] [PubMed] [Google Scholar]
  8. Bogartz L. J., Miller W. C. Pulmonary edema associated with propoxyphene intoxication. JAMA. 1971 Jan 11;215(2):259–262. [PubMed] [Google Scholar]
  9. Bracken M. B., Shepard M. J., Collins W. F., Holford T. R., Young W., Baskin D. S., Eisenberg H. M., Flamm E., Leo-Summers L., Maroon J. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990 May 17;322(20):1405–1411. doi: 10.1056/NEJM199005173222001. [DOI] [PubMed] [Google Scholar]
  10. Bradberry J. C., Raebel M. A. Continuous infusion of naloxone in the treatment of narcotic overdose. Drug Intell Clin Pharm. 1981 Dec;15(12):945–950. doi: 10.1177/106002808101501205. [DOI] [PubMed] [Google Scholar]
  11. Brimacombe J., Archdeacon J., Newell S., Martin J. Two cases of naloxone-induced pulmonary oedema--the possible use of phentolamine in management. Anaesth Intensive Care. 1991 Nov;19(4):578–580. doi: 10.1177/0310057X9101900418. [DOI] [PubMed] [Google Scholar]
  12. Buchwald A. Naloxone use: side effects may occur. Ann Emerg Med. 1988 Jul;17(7):765–765. doi: 10.1016/s0196-0644(88)80653-x. [DOI] [PubMed] [Google Scholar]
  13. Chamberlain J. M., Klein B. L. A comprehensive review of naloxone for the emergency physician. Am J Emerg Med. 1994 Nov;12(6):650–660. doi: 10.1016/0735-6757(94)90033-7. [DOI] [PubMed] [Google Scholar]
  14. Cherubin C. E. The medical sequelae of narcotic addiction. Ann Intern Med. 1967 Jul;67(1):23–33. doi: 10.7326/0003-4819-67-1-23. [DOI] [PubMed] [Google Scholar]
  15. Chiang W. K., Goldfrank L. R. Substance withdrawal. Emerg Med Clin North Am. 1990 Aug;8(3):613–631. [PubMed] [Google Scholar]
  16. Christenson J., Etherington J., Grafstein E., Innes G., Pennington S., Wanger K., Fernandes C., Spinelli J. J., Gao M. Early discharge of patients with presumed opioid overdose: development of a clinical prediction rule. Acad Emerg Med. 2000 Oct;7(10):1110–1118. doi: 10.1111/j.1553-2712.2000.tb01260.x. [DOI] [PubMed] [Google Scholar]
  17. Christenson J., Etherington J., Grafstein E., Innes G., Pennington S., Wanger K., Fernandes C., Spinelli J. J., Gao M. Early discharge of patients with presumed opioid overdose: development of a clinical prediction rule. Acad Emerg Med. 2000 Oct;7(10):1110–1118. doi: 10.1111/j.1553-2712.2000.tb01260.x. [DOI] [PubMed] [Google Scholar]
  18. Cohen M. R., Cohen R. M., Pickar D., Weingartner H., Murphy D. L., Bunney W. E., Jr Behavioural effects after high dose naloxone administration to normal volunteers. Lancet. 1981 Nov 14;2(8255):1110–1110. doi: 10.1016/s0140-6736(81)91308-8. [DOI] [PubMed] [Google Scholar]
  19. Cuss F. M., Colaço C. B., Baron J. H. Cardiac arrest after reversal of effects of opiates with naloxone. Br Med J (Clin Res Ed) 1984 Feb 4;288(6414):363–364. doi: 10.1136/bmj.288.6414.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Dettmeyer R., Schmidt P., Musshoff F., Dreisvogt C., Madea B. Pulmonary edema in fatal heroin overdose: immunohistological investigations with IgE, collagen IV and laminin - no increase of defects of alveolar-capillary membranes. Forensic Sci Int. 2000 May 15;110(2):87–96. doi: 10.1016/s0379-0738(00)00148-1. [DOI] [PubMed] [Google Scholar]
  21. Duberstein J. L., Kaufman D. M. A clinical study of an epidemic of heroin intoxication and heroin-induced pulmonary edema. Am J Med. 1971 Dec;51(6):704–714. doi: 10.1016/0002-9343(71)90298-1. [DOI] [PubMed] [Google Scholar]
  22. Estilo A. E., Cottrell J. E. Naloxone, hypertension, and ruptured cerebral aneurysm. Anesthesiology. 1981 Apr;54(4):352–352. doi: 10.1097/00000542-198104000-00025. [DOI] [PubMed] [Google Scholar]
  23. Evans J. M., Hogg M. I., Lunn J. N., Rosen M. Degree and duration of reversal by naloxone of effects of morphine in conscious subjects. Br Med J. 1974 Jun 15;2(5919):589–591. doi: 10.1136/bmj.2.5919.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Evans L. E., Swainson C. P., Roscoe P., Prescott L. F. Treatment of drug overdosage with naloxone, a specific narcotic antagonist. Lancet. 1973 Mar 3;1(7801):452–455. doi: 10.1016/s0140-6736(73)91879-5. [DOI] [PubMed] [Google Scholar]
  25. Flacke J. W., Flacke W. E., Williams G. D. Acute pulmonary edema following naloxone reversal of high-dose morphine anesthesia. Anesthesiology. 1977 Oct;47(4):376–378. doi: 10.1097/00000542-197710000-00009. [DOI] [PubMed] [Google Scholar]
  26. Flanagan R. J., Rooney C. Recording acute poisoning deaths. Forensic Sci Int. 2002 Aug 14;128(1-2):3–19. doi: 10.1016/s0379-0738(02)00158-5. [DOI] [PubMed] [Google Scholar]
  27. Frand U. I., Shim C. S., Williams M. H., Jr Methadone-induced pulmonary edema. Ann Intern Med. 1972 Jun;76(6):975–979. doi: 10.7326/0003-4819-76-6-975. [DOI] [PubMed] [Google Scholar]
  28. Fraser D. W. Methadone overdose. Illicit use of pharmaceutically prepared parenteral narcotics. JAMA. 1971 Sep 6;217(10):1387–1389. doi: 10.1001/jama.217.10.1387. [DOI] [PubMed] [Google Scholar]
  29. Gaddis G. M., Watson W. A. Naloxone-associated patient violence: an overlooked toxicity? Ann Pharmacother. 1992 Feb;26(2):196–198. doi: 10.1177/106002809202600211. [DOI] [PubMed] [Google Scholar]
  30. Gibbs J., Newson T., Williams J., Davidson D. C. Naloxone hazard in infant of opioid abuser. Lancet. 1989 Jul 15;2(8655):159–160. doi: 10.1016/s0140-6736(89)90214-6. [DOI] [PubMed] [Google Scholar]
  31. Goldfrank L., Weisman R. S., Errick J. K., Lo M. W. A dosing nomogram for continuous infusion intravenous naloxone. Ann Emerg Med. 1986 May;15(5):566–570. doi: 10.1016/s0196-0644(86)80994-5. [DOI] [PubMed] [Google Scholar]
  32. Gourlay G. K., Coulthard K. The role of naloxone infusions in the treatment of overdoses of long half-life narcotic agonists: application to nor-methadone. Br J Clin Pharmacol. 1983 Feb;15(2):269–271. doi: 10.1111/j.1365-2125.1983.tb01498.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Groeger J. S., Inturrisi C. E. High-dose naloxone: pharmacokinetics in patients in septic shock. Crit Care Med. 1987 Aug;15(8):751–756. [PubMed] [Google Scholar]
  34. Gurll N. J., Reynolds D. G., Vargish T., Lechner R. Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock. J Pharmacol Exp Ther. 1982 Mar;220(3):621–624. [PubMed] [Google Scholar]
  35. Harrington L. W. Acute pulmonary edema following use of naloxone: a case study. Crit Care Nurse. 1988 Dec;8(8):69–73. [PubMed] [Google Scholar]
  36. Hendra T. J., Gerrish S. P., Forrest A. R. Fatal methadone overdose. BMJ. 1996 Aug 24;313(7055):481–482. doi: 10.1136/bmj.313.7055.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kelly A-M, Koutsogiannis Z. Intranasal naloxone for life threatening opioid toxicity. Emerg Med J. 2002 Jul;19(4):375–375. doi: 10.1136/emj.19.4.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Labi M. Paroxysmal atrial fibrillation in heroin intoxication. Ann Intern Med. 1969 Nov;71(5):951–959. doi: 10.7326/0003-4819-71-5-951. [DOI] [PubMed] [Google Scholar]
  39. Larpin R., Vincent A., Perret C. Morbidité et mortalité hospitalières de l'intoxication aiguë par les opiacés. Presse Med. 1990 Sep 22;19(30):1403–1406. [PubMed] [Google Scholar]
  40. Lawrence J. R., Lee F. R. Letter: Ventricular fibrillation after narcotic withdrawal. Lancet. 1975 Oct 11;2(7937):717–717. doi: 10.1016/s0140-6736(75)90825-9. [DOI] [PubMed] [Google Scholar]
  41. Levin E. R., Sharp B., Drayer J. I., Weber M. A. Severe hypertension induced by naloxone. Am J Med Sci. 1985 Aug;290(2):70–72. doi: 10.1097/00000441-198508000-00005. [DOI] [PubMed] [Google Scholar]
  42. Lewis J. M., Klein-Schwartz W., Benson B. E., Oderda G. M., Takai S. Continuous naloxone infusion in pediatric narcotic overdose. Am J Dis Child. 1984 Oct;138(10):944–946. doi: 10.1001/archpedi.1984.02140480046014. [DOI] [PubMed] [Google Scholar]
  43. Longnecker D. E., Grazis P. A., Eggers G. W., Jr Naloxone for antagonism of morphine-induced respiratory depression. Anesth Analg. 1973 May-Jun;52(3):447–453. [PubMed] [Google Scholar]
  44. Louria D. B., Hensle T., Rose J. The major medical complications of heroin addiction. Ann Intern Med. 1967 Jul;67(1):1–22. doi: 10.7326/0003-4819-67-1-1. [DOI] [PubMed] [Google Scholar]
  45. Lusk J. A., Maloley P. A. Morphine-induced pulmonary edema. Am J Med. 1988 Feb;84(2):367–368. doi: 10.1016/0002-9343(88)90445-7. [DOI] [PubMed] [Google Scholar]
  46. Mariani P. J. Seizure associated with low-dose naloxone. Am J Emerg Med. 1989 Jan;7(1):127–129. doi: 10.1016/0735-6757(89)90119-8. [DOI] [PubMed] [Google Scholar]
  47. Melichar Jan K., Nutt David J., Malizia Andrea L. Naloxone displacement at opioid receptor sites measured in vivo in the human brain. Eur J Pharmacol. 2003 Jan 17;459(2-3):217–219. doi: 10.1016/s0014-2999(02)02872-8. [DOI] [PubMed] [Google Scholar]
  48. Merigian K. S. Cocaine-induced ventricular arrhythmias and rapid atrial fibrillation temporally related to naloxone administration. Am J Emerg Med. 1993 Jan;11(1):96–97. doi: 10.1016/0735-6757(93)90074-l. [DOI] [PubMed] [Google Scholar]
  49. Michaelis L. L., Hickey P. R., Clark T. A., Dixon W. M. Ventricular irritability associated with the use of naloxone hydrochloride. Two case reports and laboratory assessment of the effect of the drug on cardiac excitability. Ann Thorac Surg. 1974 Dec;18(6):608–614. doi: 10.1016/s0003-4975(10)64408-6. [DOI] [PubMed] [Google Scholar]
  50. Moore R. A., Rumack B. H., Conner C. S., Peterson R. G. Naloxone: underdosage after narcotic poisoning. Am J Dis Child. 1980 Feb;134(2):156–158. [PubMed] [Google Scholar]
  51. Mycyk Mark B., Szyszko Amy L., Aks Steven E. Nebulized naloxone gently and effectively reverses methadone intoxication. J Emerg Med. 2003 Feb;24(2):185–187. doi: 10.1016/s0736-4679(02)00723-0. [DOI] [PubMed] [Google Scholar]
  52. Osterwalder J. J. Naloxone--for intoxications with intravenous heroin and heroin mixtures--harmless or hazardous? A prospective clinical study. J Toxicol Clin Toxicol. 1996;34(4):409–416. doi: 10.3109/15563659609013811. [DOI] [PubMed] [Google Scholar]
  53. Osterwalder J. J. Patients intoxicated with heroin or heroin mixtures: how long should they be monitored? Eur J Emerg Med. 1995 Jun;2(2):97–101. doi: 10.1097/00063110-199506000-00009. [DOI] [PubMed] [Google Scholar]
  54. Partridge B. L., Ward C. F. Pulmonary edema following low-dose naloxone administration. Anesthesiology. 1986 Dec;65(6):709–710. doi: 10.1097/00000542-198612000-00037. [DOI] [PubMed] [Google Scholar]
  55. Popper C., Kelen G. D., Cunningham G. Naloxone hazard in drug abuser. Lancet. 1989 Aug 19;2(8660):446–446. doi: 10.1016/s0140-6736(89)90621-1. [DOI] [PubMed] [Google Scholar]
  56. Prough D. S., Roy R., Bumgarner J., Shannon G. Acute pulmonary edema in healthy teenagers following conservative doses of intravenous naloxone. Anesthesiology. 1984 May;60(5):485–486. doi: 10.1097/00000542-198405000-00018. [DOI] [PubMed] [Google Scholar]
  57. Redfern N. Dihydrocodeine overdose treated with naloxone infusion. Br Med J (Clin Res Ed) 1983 Sep 10;287(6394):751–752. doi: 10.1136/bmj.287.6394.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Robin E. D., Cross C. E., Zelis R. Pulmonary edema. 2. N Engl J Med. 1973 Feb 8;288(6):292–304. doi: 10.1056/NEJM197302082880606. [DOI] [PubMed] [Google Scholar]
  59. Romac D. R. Safety of prolonged, high-dose infusion of naloxone hydrochloride for severe methadone overdose. Clin Pharm. 1986 Mar;5(3):251–254. [PubMed] [Google Scholar]
  60. SADOVE M. S., BALAGOT R. C., HATANO S., JOBGEN E. A. Study of a narcotic antagonist--N-allyl-noroxymorphone. JAMA. 1963 Feb 23;183:666–668. doi: 10.1001/jama.1963.63700080011017c. [DOI] [PubMed] [Google Scholar]
  61. Sachdeva D. K., Jolly B. T. Tramadol overdose requiring prolonged opioid antagonism. Am J Emerg Med. 1997 Mar;15(2):217–218. doi: 10.1016/s0735-6757(97)90116-9. [DOI] [PubMed] [Google Scholar]
  62. Schneir Aaron B., Vadeboncoeur Tyler F., Offerman Steven R., Barry James D., Ly Binh T., Williams Saralyn R., Clark Richard F. Massive OxyContin ingestion refractory to naloxone therapy. Ann Emerg Med. 2002 Oct;40(4):425–428. doi: 10.1067/mem.2002.128143. [DOI] [PubMed] [Google Scholar]
  63. Schwartz J. A., Koenigsberg M. D. Naloxone-induced pulmonary edema. Ann Emerg Med. 1987 Nov;16(11):1294–1296. doi: 10.1016/s0196-0644(87)80244-5. [DOI] [PubMed] [Google Scholar]
  64. Smith D. A., Leake L., Loflin J. R., Yealy D. M. Is admission after intravenous heroin overdose necessary? Ann Emerg Med. 1992 Nov;21(11):1326–1330. doi: 10.1016/s0196-0644(05)81896-7. [DOI] [PubMed] [Google Scholar]
  65. Sporer K. A. Acute heroin overdose. Ann Intern Med. 1999 Apr 6;130(7):584–590. doi: 10.7326/0003-4819-130-7-199904060-00019. [DOI] [PubMed] [Google Scholar]
  66. Sporer K. A., Firestone J., Isaacs S. M. Out-of-hospital treatment of opioid overdoses in an urban setting. Acad Emerg Med. 1996 Jul;3(7):660–667. doi: 10.1111/j.1553-2712.1996.tb03487.x. [DOI] [PubMed] [Google Scholar]
  67. Steinberg A. D., Karliner J. S. The clinical spectrum of heroin pulmonary edema. Arch Intern Med. 1968 Aug;122(2):122–127. [PubMed] [Google Scholar]
  68. Taff R. H. Pulmonary edema following naloxone administration in a patient without heart disease. Anesthesiology. 1983 Dec;59(6):576–577. doi: 10.1097/00000542-198312000-00019. [DOI] [PubMed] [Google Scholar]
  69. Tanaka G. Y. Letter: Hypertensive reaction to naloxone. JAMA. 1974 Apr 1;228(1):25–26. doi: 10.1001/jama.1974.03230260019008. [DOI] [PubMed] [Google Scholar]
  70. Tenenbein M. Continuous naloxone infusion for opiate poisoning in infancy. J Pediatr. 1984 Oct;105(4):645–648. doi: 10.1016/s0022-3476(84)80440-0. [DOI] [PubMed] [Google Scholar]
  71. Vilke G. M., Buchanan J., Dunford J. V., Chan T. C. Are heroin overdose deaths related to patient release after prehospital treatment with naloxone? Prehosp Emerg Care. 1999 Jul-Sep;3(3):183–186. doi: 10.1080/10903129908958933. [DOI] [PubMed] [Google Scholar]
  72. WIKLER A., FRASER H. F., ISBELL H. N-Allylnormorphine: effects of single doses and precipitation of acute abstinence syndromes during addiction to morphine; methadone or heroin in man (post addicts). J Pharmacol Exp Ther. 1953 Sep;109(1):8–20. [PubMed] [Google Scholar]
  73. Waldron V. D., Klimt C. R., Seibel J. E. Methadone overdose treated with naloxone infusion. JAMA. 1973 Jul 2;225(1):53–53. [PubMed] [Google Scholar]
  74. Wanger K., Brough L., Macmillan I., Goulding J., MacPhail I., Christenson J. M. Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose. Acad Emerg Med. 1998 Apr;5(4):293–299. doi: 10.1111/j.1553-2712.1998.tb02707.x. [DOI] [PubMed] [Google Scholar]
  75. Ward S., Corall I. M. Hypertension after naloxone. Anaesthesia. 1983 Oct;38(10):1000–1001. doi: 10.1111/j.1365-2044.1983.tb12042.x. [DOI] [PubMed] [Google Scholar]
  76. Watson W. A., Steele M. T., Muelleman R. L., Rush M. D. Opioid toxicity recurrence after an initial response to naloxone. J Toxicol Clin Toxicol. 1998;36(1-2):11–17. doi: 10.3109/15563659809162577. [DOI] [PubMed] [Google Scholar]
  77. Whyte Ian M., Buckley Nicholas A., Dawson Andrew H. Data collection in clinical toxicology: are there too many variables? J Toxicol Clin Toxicol. 2002;40(3):223–230. doi: 10.1081/clt-120005492. [DOI] [PubMed] [Google Scholar]
  78. Wride S. R., Smith R. E., Courtney P. G. A fatal case of pulmonary oedema in a healthy young male following naloxone administration. Anaesth Intensive Care. 1989 Aug;17(3):374–377. doi: 10.1177/0310057X8901700327. [DOI] [PubMed] [Google Scholar]
  79. Yealy D. M., Paris P. M., Kaplan R. M., Heller M. B., Marini S. E. The safety of prehospital naloxone administration by paramedics. Ann Emerg Med. 1990 Aug;19(8):902–905. doi: 10.1016/s0196-0644(05)81566-5. [DOI] [PubMed] [Google Scholar]

Articles from Emergency Medicine Journal : EMJ are provided here courtesy of BMJ Publishing Group

RESOURCES